P
Parse Biosciences is a global life sciences company whose mission is to accelerate progress in human health and scientific research. Empowering researchers to perform single cell sequencing with unprecedented scale and ease, our pioneering approach is enabling groundbreaking discoveries in cancer treatment, tissue repair, stem cell therapy, kidney and liver disease, brain development, and the immune system.
Investor insights
Funding rounds participated in
$50M sweet spot round size
Investor type
Privately Held
Basic info
Industry
Biotechnology Research
Sectors
Biotechnology Research
Date founded
2018
Funding rounds raised
Total raised
$50M
from 2 investors over 1 rounds
P
Parse Biosciences raised $50M on January 14, 2024
Investors: Soleus Capital and + 4 Other investors